PAPER Jang JW, Lee SH, Kim T, Lee E, Park SW, Yeo NY, Kim YJ

Hearing loss and the risk of dementia: A longitudinal analysis of the Korean National Health Insurance Service Senior Cohort.

J Alzheimers Dis. 2025 Feb 9;:13872877251316805. Epub 2025 Feb 9 PubMed.

PAPER Amro I, Hamadi AM, Salem AA, Chivese T, Wilkins SS, Khaled SM

Population-Based Norms for the Montreal Cognitive Assessment in Arab Adults.

Brain Behav. 2025 Feb;15(2):e70287. PubMed.

PAPER Irmady K, Przedborski S

Progression in Parkinson's Disease.

Cold Spring Harb Perspect Med. 2025 Feb 10; Epub 2025 Feb 10 PubMed.

PAPER Zhou ZH, Xing HY, Liang Y, Gao J, Liu Y, Zhang T, Zhu L, Qian JL, Zhou C, Li G

[Molecular mechanism of verbascoside in promoting acetylcholine release of neurotransmitter].

Zhongguo Zhong Yao Za Zhi. 2025 Jan;50(2):335-348. PubMed.

PAPER Li Y, Zhang LL, Zhao C, Zhao HM, Wang Y, Fu JL, Zhang J, Zhang N, Xu HD

[Effect of Eucommiae Cortex extract mediated by ERβ/JNK pathway on learning and memory ability of APP/PS1 double-transgenic mice].

Zhongguo Zhong Yao Za Zhi. 2025 Jan;50(2):285-293. PubMed.

PAPER Jia X, Zhao X, Tan W, Wang Z, Du J, Guo Z, Wang T, Xu M, Liu C

Characterization of pecan, hickory, and walnut phospholipids and the comparable effects of pecan phospholipids with soy phospholipids on scopolamine-induced dementia in mice.

J Food Sci. 2025 Feb;90(2):e70055. PubMed.

PAPER Nahid S, Saeedi S, Hopkins CR

Phosphodiesterase 4 (PDE4) and neurological disorders: A promising frontier in neuropharmacology.

Adv Pharmacol. 2025;102:159-209. Epub 2024 Oct 22 PubMed.

PAPER Wei J, Meisl G, Dear AJ, Michaels TC, Knowles TP

Kinetics of Amyloid Oligomer Formation.

Annu Rev Biophys. 2025 Feb 10; Epub 2025 Feb 10 PubMed.

PAPER Yang X, Wang Y, Qiao Y, Lin J, Lau JK, Fu WY, Fu AK, Ip NY

Astrocytic EphA4 signaling is important for the elimination of excitatory synapses in Alzheimer's disease.

Proc Natl Acad Sci U S A. 2025 Feb 18;122(7):e2420324122. Epub 2025 Feb 10 PubMed.

PAPER Kaspute G, Ramanavicius A, Prentice U

Natural drug delivery systems for the treatment of neurodegenerative diseases.

Mol Biol Rep. 2025 Feb 10;52(1):217. PubMed.

PAPER Hosseinpouri A, Sadegh K, Zarei-Behjani Z, Dehghan Z, Karbalaei R

Identification of critical genes and drug repurposing targets in entorhinal cortex of Alzheimer's disease.

Neurogenetics. 2025 Feb 10;26(1):27. PubMed.

PAPER Hu M, Ye J

Clinical efficacy of donepezil combined with nerve growth factor in the treatment of patients with Parkinson's disease dementia and its impact on adiponectin and soluble tumor necrosis factor-alpha receptor-1.

Pak J Med Sci. 2025 Feb;41(2):372-377. PubMed.

PAPER

Correction to: Brain aging rejuvenation factors in adults with genetic and sporadic neurodegenerative disease.

Brain Commun. 2025;7(1):fcaf058. Epub 2025 Feb 7 PubMed. Corrected paper.

PAPER Liu L, He H, Du B, He Y

Nanoscale drug formulations for the treatment of Alzheimer's disease progression.

RSC Adv. 2025 Feb 6;15(6):4031-4078. Epub 2025 Feb 7 PubMed.

PAPER Romero-ElKhayat L, Dakterzada F, Huerto R, Carnes-Vendrell A, Mínguez O, Pujol Sabaté M, Targa A, Barbé F, Milanesi E, Dobre M, Manda G, Cuadrado A, Piñol-Ripoll G

Inflammatory and Redox Blood Gene Expression Fingerprint of Severe Obstructive Sleep Apnoea in Patients With Mild Alzheimer's Disease.

J Inflamm Res. 2025;18:1609-1621. Epub 2025 Feb 4 PubMed.